|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Goodwill impairment | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Change in fair value of derivative liabilities | |||||
| Other income, net | |||||
| Loss before income taxes | |||||
| Income tax expense | |||||
| Net loss | |||||
| Basic net loss per share (in usd per share) | |||||
| Diluted net loss per share (in usd per share) | |||||
| Basic weighted-average shares outstanding (in shares) | |||||
| Diluted weighted-average shares outstanding (in shares) | |||||
Loading...